Treatment of Leishmaniasis

Dear Colleagues,

Microorganism is announcing a Special Issue on “Leishmania”, which will be open for studies on different aspects of research on the treatment of leishmaniasis.

Leishmaniasis is caused by infection with various species of Leishmania, which presents as different types of clinical disease, each with its own treatment challenges. There is a limited number of drugs to treat leishmaniasis, and drug resistance in endemic parasite populations is limiting the clinical efficacy of current clinically used drugs. Novel therapies designed to inhibit novel target(s) in the organism or novel ways of packaging existing drugs so that they are delivered more effectively, ideally by a non-invasive route, are required. In the case of cutaneous leishmaniasis, it may be possible to combat the infection using topic photodynamic treatment.

We invite publications from scientists investigating new compounds for the treatment of leishmaniasis or novel drug delivery systems that can be used to target antileishmanial drugs to the sites of infection. We are also interested in studies investigating the use of non-drug-based therapies, e.g., light treatment, or strategies that can enhance drug treatment, e.g., immunotherapeutic interventions.

Dr. Katharine Carter
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.